Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
TRIM13 Antibody, DLEU5 Antibody, CLL-associated RING finger Antibody, LEU5 Antibody, Leukemia-associated protein 5 Antibody, RING finger protein 77 Antibody, Tripartite motif protein 13 Antibody, Putative tumor suppressor RFP2 Antibody, RFP2 Antibody, CAR Antibody, Ret finger protein 2 Antibody, RNF77 Antibody, Tripartite motif containing 13 Antibody, Tripartite motif-containing 13 Antibody
E3 ubiquitin ligase involved in the retrotranslocation and turnover of membrane and secretory proteins from the ER through a set of processes named ER-associated degradation (ERAD). This process acts on misfolded proteins as well as in the regulated degradation of correctly folded proteins. Enhances ionizing radiation-induced p53/TP53 stability and apoptosis via ubiquitinating MDM2 and AKT1 and decreasing AKT1 kinase activity through MDM2 and AKT1 proteasomal degradation.